TRPA1 and asthma: GDC-0334 is a potent oral TRPA1 antagonist that inhibits the effects of TRPA1 on airway smooth muscles and sensory neurons, reduces edema, dermal blood flow, cough, and allergic airway inflammation, and treats asthma (Balestrini et al., 2021).